Baqsimi is a nasal spray formulation of glucagon, already widely used as an injectable treatment for hypoglycaemia, which can occur when people with diabetes inadvertently take too much insulin.

Glucagon is a recognised therapy for the disorder ... as a hypoglycaemia rescue therapy for diabetics. Eli Lilly's nasal spray Baqsimi was also approved in 2019 for a similar indication.

The FDA has expanded the approval of Valtoco (diazepam nasal spray) to include treatment of seizure clusters in patients aged 2 to 5 years.

Here's the lowdown from allergy doctors on how to get relief, from which medicines to use — and how to best use them — to tips for keeping pollen out of your home.

California is ramping up efforts to combat the opioid epidemic by rolling out online sales of a drug that can reverse ...

An alternative, nasal spray, formulation has been developed that demonstrates good efficacy, high tolerability and a very fast onset of action. This study assessed the pharmacokinetics and ...

With allergy season in full swing, Dr. Purvi Parikh joins Saturday TODAY to break down why many may be experiencing worse ...

Manufacturers of impotence pills are facing a new challenge in the form of a nasal spray that acts in just eight minutes. The Aspirair device is similar to an asthma inhaler, and administers ...

Experts have warned that blockbuster jabs like Ozempic and Mounjaro can raise the risk of depression and suicidal thoughts, potentially leaving patients 'dying to lose weight'. The medicines could ...